Customers

Credit Suisse

Credit Suisse saved significant time and accelerated M&A processes using the Q&A functionality of SS&C Intralinks.

“The Intralinks Q&A functionality makes my life much easier. You can quickly see what questions have and have not been answered, and it allows our executives to stay on top of deal progress. Using Intralinks, I can give status updates and answer queries in real time. It also makes it easy to facilitate questions between different buyers.” – Justin Hales M&A Investment Banking Analyst Credit Suisse

View the full case study

You're in good company

We care as much about the deal as you do.

Our Customer Success Managers and Support Specialists go the extra mile
to make sure you have everything you need. 

M&A Deal Tombstones

For over two decades, we have facilitated over $34 trillion USD worth of transactions. That's a lot of deals. 

See all tombstones

Royalty Pharma

US$2.2 billion

Royalty Pharma
Royalty Pharma used Intralinks for its IPO, raising $2.2 billion IPO proceeds.
Generate Life Sciences

US$1.605 billion

Generate Life Sciences
GI Partners LLP used Intralinks for its sale of Generate Life Sciences to Cooper Cos Inc, for an estimated USD 1.605 billion.
EAG Laboratories

US$780 million

EAG Laboratories
EAG Laboratories, a US-based global scientific services company providing advanced analytical testing and consulting solutions, used Intralinks for its acquisition by Eurofins Scientific from Odyssey Investment Partners for US$780 million.
Deerland
Deerland Probiotics & Enzymes
Archer Daniels Midland Co acquired Deerland Probiotics & Enzymes Inc, a Kennesaw-based manufacturer of medicinals and botanicals.​
One Rock Capital Partners III

US$2.01 billion

One Rock Capital Partners III
One Rock Capital Partners III seeks to invest in North America-based mid-market companies across a diverse range of industries.
carousellogo.jpg

US$700 million

Carousel Capital Partners VI
Carousel Capital Partners VI focuses on acquiring non-cyclical, growth-oriented companies headquartered in Southeastern U.S.
true-ventures.png

US$465 million

True Ventures
True Ventures VII is an early stage venture capital fund which invests in technology startups, including ecommerce, consumer devices, media, mobile, software and services.

US$17.77 billion

Thoma Bravo Fund XIV
Thoma Bravo Fund XIV is the 14th fund in the series. The fund will continue to invest in the software and technology sectors.

US$200 million

Eureka IV
Eureka IV targets investments in profitable businesses with up to USD 100 million in revenue. The fund focuses on companies located in the Mid-Atlantic and Eastern US.

We can help you get started

Get in touch to start tailoring your plan.